US Patent 11497198 Genetically modified mice expressing humanized CD40
Patent 11497198 was granted and assigned to Biocytogen on November, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11497198 Genetically modified mice expressing humanized CD40
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.